Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies

BACKGROUND AND OBJECTIVES: Complicated vascular anomalies have limited therapeutic options and cause significant morbidity and mortality. This Phase II trial enrolled patients with complicated vascular anomalies to determine the efficacy and safety of treatment with sirolimus for 12 courses; each co...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Pediatrics
Autors principals: Adams, Denise M., Trenor, Cameron C., Hammill, Adrienne M., Vinks, Alexander A., Patel, Manish N., Chaudry, Gulraiz, Wentzel, Mary Sue, Mobberley-Schuman, Paula S., Campbell, Lisa M., Brookbank, Christine, Gupta, Anita, Chute, Carol, Eile, Jennifer, McKenna, Jesse, Merrow, Arnold C., Fei, Lin, Hornung, Lindsey, Seid, Michael, Dasgupta, A. Roshni, Dickie, Belinda H., Elluru, Ravindhra G., Lucky, Anne W., Weiss, Brian, Azizkhan, Richard G.
Format: Artigo
Idioma:Inglês
Publicat: American Academy of Pediatrics 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4732362/
https://ncbi.nlm.nih.gov/pubmed/26783326
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1542/peds.2015-3257
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars